Forte Biosciences, Inc.FBRXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P44
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2024-7.10%
2023-250.71%
202250.92%
20219.48%
2020-564.85%
201991.96%
2018-10.72%
2017-5.40%
2016-40.38%
20150.00%